patent

British drugmaker GlaxoSmithKline on Thursday filed a patent infringement action against in the Delhi High Court, alleging that the latter’s Vilor F medicine infringes GSK’s Indian patent for vilanterol, an active ingredient. Glenmark’s product used for the treatment of chronic obstructive pulmonary disease (COPD) has two active ingredients – fluticasone furoate, a corticosteroid, and vilanterol,…Continue Reading